Abemaciclib treatment patterns and outcome in HR+/HER2- locally advanced or metastatic breast cancer: a real-world study from Kuwait and Lebanon

Abemaciclib treatment patterns and outcome in HR+/HER2- locally advanced or metastatic breast cancer: a real-world study from Kuwait and Lebanon

PurposeThe burden of breast cancer is still growing in the Middle East and North Africa (MENA). BC patients typically present with more advanced stages than in Western countries. Limited information is available regarding the safety and efficacy of novel molecules for advanced BC in the Middle East...

Full description

Saved in:
Bibliographic Details
Main Authors: Anwar Al Nouri, Faisal Al Terkait, Nagi El Saghir, Hady Ghanem, Joseph Kattan, Cynthia Bishouti, Jade Dreyer, Soniya Rai, Alexandru Rosca
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Oncology
Subjects:
breast neoplasms
disease-free survival
CDK inhibitor
abemaciclib
metastatic breast cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1437380/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1437380/full

Similar Items